pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    urcosimod
    urcosimod
    Keratoconjunctivitis Sicca (Dry Eye)$OKYO OKYO Pharma Ltd
  • Phase 3
    vamikibart
    vamikibart
    Panuveitis F. Hoffmann-La Roche Ltd
  • pre_registration
    veligrotug
    veligrotug [INN]
    Graves' Ophthalmopathy Viridian Therapeutics Inc
  • Phase 3
← prev
page 13 of 13
next →
Pain89
Neurology1
vezocolmitide hydrochloride
vezocolmitide hydrochloride
Keratoconjunctivitis Sicca (Dry Eye)
Stuart Therapeutics Inc
  • Phase 3
    vonaprument
    vonaprument
    Geographic Atrophy$ANNX Annexon, Inc.
  • Phase 2
    voretigene neparvovec
    Luxturna (voretigene neparvovec-rzyl)
    Choroideremia F. Hoffmann-La Roche Ltd
  • Phase 3
    vorolanib
    DURAVYU (vorolanib [INN])
    Wet (Neovascular / Exudative) Macular Degeneration$EYPT EyePoint, Inc.
  • Phase 2
    xelafaslatide
    xelafaslatide
    Retinal Pigment Epithelial (RPE) Detachment ONL Therapeutics Inc